US Stock MarketDetailed Quotes

KAPA Kairos Pharma

Watchlist
  • 0.970
  • +0.010+1.04%
Close Mar 27 16:00 ET
  • 0.970
  • 0.0000.00%
Post 20:01 ET
13.29MMarket Cap-4.62P/E (TTM)

About Kairos Pharma Company

Kairos Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of novel and transformative drug therapies to treat cancer. It focuses on the research and development of immunotherapies for oncology. The company was founded by John S. Yu on June 17, 2013 and is headquartered in Los Angeles, CA.

Company Profile

SymbolKAPA
Company NameKairos Pharma
Listing DateSep 16, 2024
Founded2013
CEODr. John S. Yu,M.D.
MarketAMEX
Employees3
Fiscal Year Ends12-31
Address2355 Westwood Boulevard,Suite 139
CityLos Angeles
ProvinceCalifornia
CountryUnited States of America
Zip Code90064
Phone1-310-948-2356

Company Executives

  • Name
  • Position
  • Salary
  • Dr. John S. Yu,M.D.
  • Chairman of the Board and Chief Executive Officer
  • --
  • Neil Bhowmick
  • Chief Scientific Officer
  • --
  • Doug Samuelson
  • Chief Financial Officer
  • --
  • Ramachandran Murali, PhD
  • Vice President of Research and Development
  • --
  • Dr. Rahul Singhvi, Sc.D.
  • Director
  • --
  • Hyun W. Bae, M.D.
  • Independent Director
  • --
  • Dr. Hansoo Michael Keyoung, M.D.,PhD
  • Independent Director
  • --

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More